Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.

Kipfer ET, Schön J, Chami M, Finke S, Beer M, Hoffmann D, Otte F, Hauser D

Open source

DOI
10.1016/j.isci.2026.117521
Published
2026 Oct 16
Container
iScience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2026.117521,
  title = {Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.},
  author = {Kipfer ET and Schön J and Chami M and Finke S and Beer M and Hoffmann D and Otte F and Hauser D},
  year = {2026},
  journal = {iScience},
  doi = {10.1016/j.isci.2026.117521},
  url = {https://doi.org/10.1016/j.isci.2026.117521}
}

RIS

TY  - JOUR
TI  - Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.
AU  - Kipfer ET
AU  - Schön J
AU  - Chami M
AU  - Finke S
AU  - Beer M
AU  - Hoffmann D
AU  - Otte F
AU  - Hauser D
PY  - 2026
JO  - iScience
DO  - 10.1016/j.isci.2026.117521
UR  - https://doi.org/10.1016/j.isci.2026.117521
ER  - 

APA

ET, K., J, S., M, C., S, F., M, B., D, H., F, O., & D, H. (2026). Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.. iScience. https://doi.org/10.1016/j.isci.2026.117521

Source records